| abstract |
The invention describes compounds of formula (I) and enantiomers, diastereomers and pharmaceutically acceptable salts thereof. The compounds of formula (I) are protein kinase inhibitors and are useful in the treatment of proliferative or rapidly progressing diseases such as cancer, inflammation and arthritis. They are also useful in the treatment of Alzheimer's disease, chemotherapy-induced baldness and cardiovascular disease.ŕ |